Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

When my father and his brothers all died of prostate cancer in the 1990s, it was still considered an “old man’s disease” and ...

Sansum Clinic and Ridley-Tree Cancer Center will share a panel discussion that was presented on prostate health. To view the video presentation, click ...

During September’s Prostate Cancer Awareness Month, MidLantic Urology is reminding men of a critical point. It's 0.75. If your PSA increases by 0.75 in 1 year, it could be prostate cancer, and it’s ...

Millions of men in the United States have had the blood test called PSA, which can detect prostate cancer early. No one knows whether getting the test reduces a man's chances of dying of the disease.

A new British study suggests that the prostate-specific antigen (PSA) test, long used to spot prostate cancers, might lead to overdiagnosis in Black men. Researchers now theorize that Black men may ...

Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

Prostate cancer blood tests can lead to men being over-tested, while those who need help may be missed, a large study has found. Researchers from the University of Oxford examined the health records ...

The largest study to date investigating a single invitation to a PSA blood test* to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and ...

A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis. Prostate-specific antigen (PSA) ...